UnitedHealth Group (NYSE:UNH) Stock Sold Rep. Dan Newhouse

Representative Dan Newhouse (Republican-Washington) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on July 17th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on July 10th. The trade occurred in the Representative’s “EDWARD JONES IRA” account.

Representative Dan Newhouse also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Costco Wholesale (NASDAQ:COST) on 7/10/2026.
• Sold $1,001 – $15,000 in shares of Deere & Company (NYSE:DE) on 7/10/2026.
• Purchased $1,001 – $15,000 in shares of Arista Networks (NYSE:ANET) on 7/10/2026.
• Sold $1,001 – $15,000 in shares of United Parcel Service (NYSE:UPS) on 7/10/2026.
• Sold $1,001 – $15,000 in shares of Hershey (NYSE:HSY) on 7/10/2026.
• Purchased $1,001 – $15,000 in shares of Duke Energy (NYSE:DUK) on 7/10/2026.
• Purchased $1,001 – $15,000 in shares of Amcor (NYSE:AMCR) on 7/10/2026.
• Sold $1,001 – $15,000 in shares of Fortinet (NASDAQ:FTNT) on 7/10/2026.
• Sold $1,001 – $15,000 in shares of Magna International (NYSE:MGA) on 7/10/2026.
• Purchased $1,001 – $15,000 in shares of Accenture (NYSE:ACN) on 7/10/2026.

UnitedHealth Group Stock Up 2.3%

Shares of UNH stock traded up $9.86 during trading on Tuesday, reaching $431.41. The company’s stock had a trading volume of 931,652 shares, compared to its average volume of 8,417,531. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.80. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $461.62. The company has a market capitalization of $391.78 billion, a price-to-earnings ratio of 27.73, a P/E/G ratio of 1.67 and a beta of 0.62. The stock’s 50-day moving average price is $405.55 and its 200 day moving average price is $343.00.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The business had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. During the same quarter in the prior year, the company earned $4.08 earnings per share. The company’s revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 18.77 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were paid a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date was Monday, June 15th. UnitedHealth Group’s payout ratio is currently 59.72%.

Institutional Trading of UnitedHealth Group

Several institutional investors have recently added to or reduced their stakes in the business. Sarver Vrooman Wealth Advisors acquired a new stake in UnitedHealth Group in the fourth quarter worth $25,000. Beacon Financial Strategies CORP bought a new position in UnitedHealth Group in the 4th quarter worth about $26,000. Anfield Capital Management LLC raised its holdings in shares of UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after buying an additional 55 shares during the last quarter. Joseph Group Capital Management acquired a new stake in UnitedHealth Group in the 4th quarter valued at approximately $27,000. Finally, Nalls Sherbakoff Group LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $27,000. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. This trade represents a 4.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.19% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on UNH shares. Morgan Stanley increased their target price on shares of UnitedHealth Group from $468.00 to $529.00 and gave the stock an “overweight” rating in a research note on Friday. Barclays upped their target price on UnitedHealth Group from $429.00 to $441.00 and gave the company an “overweight” rating in a research note on Monday. Zacks Research raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. Cantor Fitzgerald restated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, June 11th. Finally, Jefferies Financial Group boosted their price target on UnitedHealth Group from $340.00 to $373.00 and gave the stock a “buy” rating in a research report on Monday, April 20th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $454.00.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Analysts at Barclays raised their price target on UnitedHealth Group to $441 and reiterated an overweight rating, signaling more upside from current levels. Benzinga report on Barclays price target hike
• Positive Sentiment: Truist, Oppenheimer, and KeyBanc also lifted targets to $500, with Oppenheimer saying UnitedHealth “handily” beat expectations, reinforcing the case for continued momentum. Stocktwits article on analyst target increases
• Positive Sentiment: Multiple articles point to strong quarterly performance and a potential move toward $500, suggesting investors are pricing in continued earnings strength and improving sentiment. Motley Fool article on UNH heading to $500
• Positive Sentiment: UnitedHealth announced a $5 billion buyback, which investors may view as management confidence in the company’s turnaround and a support for shareholder returns. Barchart article on $5 billion buyback
• Neutral Sentiment: UnitedHealth is also being highlighted in dividend and momentum stock screens, which adds to visibility but is less likely to move the stock on its own. Yahoo Finance dividend stock article
• Neutral Sentiment: A House bill aimed at tougher provider accountability passed 396-0, but the direct impact on UNH is unclear and likely limited near term. Quiver Quant bill summary
• Negative Sentiment: One article noted that UnitedHealth’s CFO warned investors that cost pressures are still not fully resolved, which could temper enthusiasm despite the strong earnings beat. TheStreet article on CFO cost warning

About Representative Newhouse

Dan Newhouse (Republican Party) is a member of the U.S. House, representing Washington’s 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.

Newhouse (Republican Party) ran for re-election to the U.S. House to represent Washington’s 4th Congressional District. He won in the general election on November 5, 2024.

Click here to see Newhouse’s key votes in Congress.

Newhouse served as a member of the Washington House of Representatives representing District 15-Position 2 from 2003 through 2009 and as Washington Director of Agriculture from 2009 to 2013.

Newhouse was first elected to the state House in 2002 and served until he was named state Director of Agriculture in 2009. He was first appointed by Governor Christine Gregoire on February 18, 2009.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.